Duke-NUS expands research capabilities with appointment of Professor Hendrik Luesch from UF

FHS
July 30, 2024
5:54 pm

Duke-NUS Medical School today announced the appointment of Professor Hendrik Luesch from the University of Florida (UF) as a joint faculty member.

Pazopanib activity confirmed in EWSR1-NFATC2 bone sarcoma

A new case report was published in Oncoscience (Volume 10) on September 20, 2023, entitled, “Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma.”

January 13, 2024

It takes GUTS to be BOLD: A look at the new biotech tickers

As the public markets heat up in biotech, industry insiders expect a small drumbeat of IPOs later this spring, and that means a new set

March 16, 2024

Vigorous exercise linked to lower dementia risk in hypertensive individuals

The effect of vigorous physical activity (VPA) on the risk of incident mild cognitive impairment (MCI) and probable dementia.

June 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.